Exam 4: Intra-Abdominal Infections (IAI) Flashcards

1
Q

What are the 2 types of primary peritonitis?

A

Peritoneal Dialysis Related Peritonitis

Spontaneous Bacterial Peritonitis (no known cause)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the types of secondary peritonitis?

A

*Diverticulitis
*Appendicitis
*Intra-abdominal abscess

Cholecystitis
Cholangitis
Necrotizing Pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is an uncomplicated infection?

A

Confined to one organ or space, does not extend to peritoneum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a complicated infection?

A

Extends beyond a single organ into the peritoneal space and is associated with peritonitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What criteria must be met for an infection to be considered “community acquired”?

A

Occurs within 48 hours of hospital admission

No healthcare exposure

-Caused by normal intra-abdominal flora

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What criteria must be met for an infection to be considered “healthcare-associated”?

A

Occurs after 48 hours of hospital admission
or
Healthcare exposure in the last 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the source of contamination for Spontaneous Bacterial Peritonitis?

A

No obvious source of contamination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Who is at highest risk for spontaneous bacterial peritonitis (SBP)?

A

Hepatic failure and ascites (alcoholic cirrhosis)

Continuous ambulatory peritoneal dialysis (CAPD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the most common pathogen in spontaneous bacterial peritonitis (SBP)?

A

E. coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do we diagnose spontaneous bacterial peritonitis (SBP)?

A

Ascitic Fluid Analysis

-Low ascitic fluid protein (<2.5 g/dL)
*Absolute neutrophil count > 250/mm^3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do we calculate absolute neutrophil count?

A

Total Nucleated Cells (TNC) x Bands/Neutrophils %

ex:
TNC= 705
Bands/Neutrophils= 96%

705 x 0.96= 676 (high)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the drug of choice for Spontaneous Bacterial Peritonitis empiric therapy?

A

Ceftriaxone 102 g IV q 24 h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are other empiric options for Spontaneous Bacterial Peritonitis besides Ceftriaxone?

A

Cefepime IV
Piperacillin/Tazobactam IV
Meropenem IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

If S aureus/ Coagulase negative staphylococci are present in Spontaneous Bacterial Peritonitis or if there is a risk for MRSA what drugs can be added to the treatment?

A

Vancomycin IV
Linezolid IV
Daptomycin IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

If we need anaerobic coverage in Spontaneous Bacterial Peritonitis what drugs can we add to the treatment regimen?

A

Beta-lactam/ Beta -lactamase inhibitor

Carbapenem

Metronidazole

(ex of anaerobes: bacteroides, legionella, C diff, peptococcus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When is it appropriate to transition to oral therapy in Spontaneous Bacterial Peritonitis?

A

Once clinical stability is achieved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How long does treatment for Spontaneous Bacterial Peritonitis last?

A

In patient with cirrhosis and ascites: 5-7 days

Continuous Ambulatory Peritoneal Dialysis: 14-21 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Who should receive secondary prophylaxis with Spontaneous Bacterial Peritonitis?

A

Patients with cirrhosis and ascites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What drugs can we use for secondary prophylaxis in Spontaneous Bacterial Peritonitis?

A

TMP/SMX DS po once daily
or
Ciprofloxacin 500 mg po once daily

20
Q

What is the most common pathogen in secondary peritonitis?

21
Q

What makes secondary peritonitis therapy complicated?

A

It is normally polymicrobial

22
Q

What bacteria could possibly cause secondary peritonitis but are not common?

A

Staphylococcus aureus (MRSA is uncommon)

Pseudomonas

23
Q

What makes intraabdominal infections unique?

A

Multiple organ systems are affected

Bacterial synergy

24
Q

What are signs that the GI tract has an infection?

A

Bowel paralysis -> Abdominal distention

25
Q

What are signs that the cardiovascular system is infected?

A

Fluid shifts -> hypotension, tachycardia, vasoconstriction

26
Q

What are signs that the respiratory system is infected?

27
Q

What are signs that the renal system is infected?

A

Decreased renal perfusion -> Renal failure

28
Q

What bacterial synergy is commonly seen in intra-abdominal infections?

A

Enterobacterales (e. coli) create an optimal environment for anaerobic bacteria (they use up all the oxygen)

Anaerobes cause abscess formation and have several virulence factors

*we need to cover both aerobes and anaerobes

29
Q

How do we diagnose an intra-abdominal infection?

A

Signs + Symptoms
+
Imaging (CT scan or x-ray)

30
Q

What are the 2 treatment pathways in intra-abdominal infections?

A

Source Control

Antimicrobial Therapy

31
Q

What are examples of source control in intra-abdominal infections?

A

Repair perforations

Resection of infected organs/ tissue

Removal of foreign material

Drain purulent collections

make sure to obtain cultures

32
Q

What 3 considerations need to be made when choosing empiric antibiotic therapy for secondary peritonitis?

A
  1. Select agents or combinations that have a high likelihood to cover common organisms
    Look at antibiogram
  2. Consider if enterococci coverage is necessary
  3. Consider if antifungal coverage is necessary
33
Q

An agent is generally not recommended if resistance exceeds what on an antibiogram?

A

10-20%

(need to have 80-90% efficacy)

34
Q

When is Enterococci coverage not needed?

A

Mild-Moderate severity community acquired intraabdominal infection

35
Q

Who should receive Enterococci coverage for intra-abdominal infection?

A

High severity
History of cephalosporin use
Immunocompromised
Biliary source of infection

History of valvular heart disease
and/or
Prosthetic intravascular material

36
Q

When would we consider prophylactic antifungal coverage in an intra-abdominal infection?

A

If patient not improving on appropriate antibiotic therapy

Esophageal perforation

37
Q

What are the possible empiric therapy options for secondary peritonitis/ intra-abdominal infections that are community-acquired and mild-moderate?

A

Ceftriaxone IV + Metronidazole IV/PO
Cefazolin IV+ Metronidazole IV/PO
Ciprofloxacin IV + Metronidazole IV/PO
Levofloxacin IV + Metronidazole IV/PO

Cefoxitin IV
Ertapenem IV
Tigecycline IV

38
Q

What are the possible empiric therapy options for secondary peritonitis/intra-abdominal infections that are either community acquired with high severity or healthcare-associated?

A

Piperacillin/Tazobactam IV
Meropenem IV
Cefepime IV + Metronidazole IV/PO
Ciprofloxacin IV + Metronidazole IV/PO
Levofloxacin IV + Metronidazole IV/PO

*note that cipro and cefe need extra enterococci coverage

39
Q

What are the treatment options if we need antifungal coverage in secondary peritonitis/intra-abdominal infections (candida species)?

A

Candida albicans: Fluconazole IV/PO

Candida others: Micafungin IV

40
Q

What drug is not used in secondary peritonitis/intra-abdominal infections due to resistance?

A

Ampicillin/Sulbactam

41
Q

Which drug class should we try to avoid if possible?

A

Fluoroquinolones

(do not pick these if other options are available) (ciprofloxacin, levofloxacin)

42
Q

What points are important to remember about anaerobic coverage?

A

More difficult to isolate in culture

Common to maintain anaerobic coverage even if culture does not isolate anerobic bacteria

we will almost always maintain anaerobic coverage

43
Q

When can we transition to oral therapy?

A

When clinical stability is achieved

44
Q

What are the possible oral regimens we can use for intra-abdominal infections/ secondary peritonitis?

A

Amox/Clav PO q8h

Cefpodoxime + Metronidazole
Cephalexin + Metronidazole
Cefadroxil + Metronidazole
Ciprofloxacin + Metronidazole
Levofloxacin + Metronidazole
TMP/SMX + Metronidazole

45
Q

How long should general intra-abdominal infections be treated for?

A

4-7 days after source control